The honest comparison
Manual entry isn’t always wrong. For ad-hoc, single-PDF cases — or in a lab that has one technician, one instrument, and 1 report a week — it can be the lowest-friction option. The math changes fast as volume goes up.
| Dimension | Manual entry | ChromaParse |
|---|---|---|
| Speed (per page) | ~3-5 min for a typical peak table | ~5 sec |
| Error rate | 0.5-1.0% per cell (industry average) | <0.1% |
| Source-trace | None — re-checking requires rereading the PDF | Click any cell → highlight in PDF |
| Audit log | Operator’s name on a paper form, maybe | Per-action with timestamp, file hash, bbox |
| Setup cost | Zero | Account creation, ~5 min |
| Marginal cost | High (~hour of QC analyst time per 20-page report) | ¥0.30-1.00 per page |
| Compliance | Requires double-review under NMPA 2024 | Single-pass, source-trace audit-ready |
When manual is still fine
- One report per week or less — automation overhead doesn’t pay back
- Non-regulated environments — research labs without GMP scope
- Bridging period — while validation work for ChromaParse is still in progress
When ChromaParse is the better answer
- Daily QC — even one analyst processing 5 reports/day saves >2 hours
- GMP / NMPA scope — double-review burden of manual transcription often justifies the tool
- LIMS migration — historical data extraction at scale is impractical manually
- Audit pressure — when an inspector asks “prove this Excel cell came from this PDF”, source-trace gives an immediate answer
The break-even point
For most pharma QC labs, ChromaParse Super (¥99/mo) pays for itself if it saves 2 hours of analyst time per month. That’s typically less than two 50-page reports.